Khulan TS, Ambaga M and Chimedragcha CH
Introduction: In diabetes therapy, a great attention is paid on lowering blood glucose levels and lipid regulating mechanisms of various medica..Voir plus»
Ken CN Chang*, Yun Zhao, John Kang, Saumya Pant, Ping Qiu, Bo Wei, Russell Weiner and Matthew J Marton
Use of a Next Generation Sequencing (NGS)-based test as a clinical trial assay requires that the test be analytically validated to CLIA/CAP regulations. During the course of ana..Voir plus»
Fernando Gomez-Peralta, Antonio Lopez-Guzman, Manuel Delgado, Rocio Villar-Taibo, Cristina Abreu, Estefanía Santos, Luis Santiago, Victor Puigdeva
Introduction and objectives: Diabetes mellitus type 1 (DM1) represents 5–10% of the total prevalence of diabetes. Few studies exist to demographically and clinically descr..Voir plus»
Abraham Kalfoury
Background: It has been hypothesized that the major histocompatibility complex (MHC) genes are the primary genetic factor in the predisposition to type 1 ..Voir plus»
Subhankar Chowdhury, Jyothi Raman Chowdhury and Soumik Goswami
Dyslipidaemia is a major contributor to cardiovascular disease which has assumed epidemic proportions worldwide. The traditional approach to the management of dyslipidaemia focu..Voir plus»
Fahimeh Ramezani Tehrani, Maryam Tohidi, Marzieh Rostami Dovom and Fereidoun Azizi
Introduction: Although overt hypothyroidism is a known risk factor for cardiovascular disease, there is no consensus regarding the impact of subclinical hypothyroidism (SCH) on ..Voir plus»